appeals for gip glp 1 GLP-1 Weight Loss and Diabetes Beyond the pancreas: contrasting cardiometabolic
Description
35-54 Age Group Emerges as Key Target Demographic The 35-54 age group held a 30.6% share in 2024 and is forecast to reach 33% in 2025
Worldwide, more than one billion people are obese, leaving individuals susceptible to a host of health conditions like diabetes, heart disease, and some cancers
Notably, Illinois adopted legislation in 2024 that requires coverage of certain weight loss and obesity medications in the state employee health plan
The downsides are nausea, vomiting, upset stomach, and hair loss in some patients
